Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 21.20
Bid: 21.20
Ask: 21.55
Change: 0.00 (0.00%)
Spread: 0.35 (1.651%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 21.20
ALL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of RosterOn in Australia

5 Jul 2011 07:00

RNS Number : 7711J
Allocate Software PLC
05 July 2011
 



 

5 July 2011

 

ALLOCATE SOFTWARE PLC

("Allocate" or "the Company")

 

Acquisition of RosterOn in Australia

 

Allocate Software plc announces that it has acquired RosterOn Pty Ltd ("RosterOn"), an Australian based provider of workforce management software with a focus on the Australian healthcare market, for A$3.0 million (£2.0 million)1 (the "Acquisition"). This gives Allocate a much stronger local presence and is in line with its ambitious growth plans for the Australian healthcare market.

 

Overview of RosterOn and the Acquisition

§ RosterOn is a leading, local Australian provider of staff rostering software, principally for the Australian healthcare market

§ RosterOn has product functionality complementary to Allocate's, including an Awards interpretation engine tailored specifically for the Australian Market (complex rules relating to salary fixing arrangements)

§ c. 70% of revenues come from RosterOn's 43 healthcare customers according to unaudited management accounts, with the balance spread across multiple sectors including mining, logistics, manufacturing and retail

§ In the year ended 30 June 2011, unaudited management accounts show c. A$3.0 million in revenues and approximately A$0.6 million in EBITA

§ All 17 RosterOn employees will be retained

§ Upfront consideration of A$2.6 million payable in cash with further consideration of A$0.4 million payable in cash and in full upon the retention of the key directors of RosterOn for 18 months from completion

§ The Board believes the acquisition will accelerate the expansion of Allocate's business in Australia and that it will be earnings enhancing, before one time deal costs, in the financial year to 31 May 2012

 

Information on RosterOn

RosterOn was founded in 2002 and is based outside Melbourne, Victoria, Australia. It is a leading provider of rostering, labour management, and time & attendance software in Australia. RosterOn has developed an interpretation engine specifically for Australian Awards - complex rules for wage fixing arrangements relating to minimum pay, minimum number of breaks per hour, minimum level of overtime compensation and pay related activities (e.g. working through a break).

 

Customer Base

All of RosterOn's customers are based in Australia.

 

As at 31 May 2011, RosterOn had 68 customers, 43 of which are in the healthcare sector. RosterOn's installed base is therefore a complementary fit to Allocate's existing presence in Australia, with two state wide projects underway, as previously announced.

 

Technical Environment

The front-end of RosterOn's core product is implemented using C++ .NET with an SQL server back-end and has been developed by RosterOn using industry standard tools. Allocate has conducted detailed technical due diligence and believes that the technology architecture is robust and scalable.

 

Management and Employees of RosterOn

The Company does not expect a complex integration of RosterOn into the Allocate group. Key members of RosterOn's management and all of the team are expected to remain in place after the Acquisition.

 

Acquisition Rationale

Given Allocate's ambitious growth plans for the local market, the Board believes that this acquisition will accelerate the expansion of its presence in the Australian healthcare market. The acquisition of a local provider of workforce management software with an established installed base in the Australian healthcare market leverages Allocate's strategy to provide scale and resources to accelerate its growth in the region.

 

Commenting on the Acquisition, Ian Bowles, CEO of Allocate, said: "I am delighted to have completed this, our fifth acquisition. Acquiring RosterOn reinforces our commitment to the local market and consolidates our position in the Australian healthcare sector. Furthermore, RosterOn brings additional domain expertise and complimentary applications functionality for Healthcare in Australia. I believe this is a timely opportunity to add scale and expertise to our existing Australian operations and I am very pleased that both of the founders, Dean and Peter will remain with the Allocate Group, reporting to Peter Croft, our General Manager for Australia and New Zealand."

 

Dean Seeley and Peter Collins, founders and directors of RosterOn, said: "The strategic fit between Allocate and RosterOn is excellent for both customers and staff. Healthcare has emerged as one of the most exciting areas of the workforce management software market and the enlarged group is well positioned to exploit this opportunity. In addition, our installed base of 25 customers in sectors outside of healthcare is complementary to Allocate's opportunities for development in Australia. We look forward to contributing to their continued strong growth."

 

 

Final Results FY11 date

In its Q4 Update and Contract Wins, the Company announced that it would release its FY11 year end results w/c 8th August. The Company has now decided to move that date to September 5th in order to enable the optimal level of resource to be applied in the first 30 days of this acquisition.

 

 

Enquiries:

Allocate Software plc

Ian Bowles - Chief Executive Officer

Chris Gale - Chief Financial Officer

 

Tel: +44 (0) 20 7355 5555

Strata Partners (Financial Adviser)

Edward Roskill

Alistair Armstrong-Brown

 

Tel: +44 (0) 20 7730 1200

Numis Securities Limited (NOMAD / Corporate Broker)

Nominated adviser - Michael Meade

Corporate Broking - James Black

 

 

Tel: +44 (0) 20 7260 1000

Gable Communications

Justine James

John Bick

 

Tel: +44 (0) 20 7193 7463

+44 (0) 7525 324 431

 

 

 

About Allocate Software plc

Allocate Software plc is the leading workforce and compliance optimisation software applications provider for world-wide organisations with large, multi-skilled workforces. With a blue chip client base spanning the public and private sector, its key vertical markets include: Healthcare, Defence and Maritime.

At the core of the business is Allocate's workforce optimisation software, which organisations use to deploy the right people with the right skills, to the right place at the right time. Headquartered in London, Allocate provides services and support to its increasing international customer base through regional offices in the UK, Sweden, USA, Australia and Malaysia.

Allocate is quoted on the London Stock Exchange (AIM: ALL). For further information please visit www.allocatesoftware.com.

 

______________________________

1 £1 = A$1.50 as at 1 July 2011

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQSSFSIIFFSEDW
Date   Source Headline
2nd May 20247:00 amRNSApproval to List on the Ghana Stock Exchange
24th Apr 20247:00 amRNSQuarterly Activities and Cash Flow Report
18th Apr 20247:00 amRNSExploration-focused Investor Webinar
16th Apr 20247:00 amRNSInvestor Presentation - Paydirt Battery Minerals
8th Apr 20247:00 amRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSFurther Broad and High-Grade Drill Intersections
15th Mar 20247:00 amRNSHalf-year Financial Report
27th Feb 20247:00 amRNSConference Attendance
15th Feb 20247:00 amRNSDirector/PDMR Dealings
5th Feb 20247:00 amRNSMultiple Broad and High-Grade Drill Intersections
2nd Feb 20247:00 amRNSConference Attendance – Mining Indaba
1st Feb 20248:20 amRNSInvestor Presentation - Investor Webinar
31st Jan 20247:00 amRNSQuarterly Activities and Cash Flow Report
29th Jan 20247:00 amRNSInvestor Webinar
25th Jan 20247:00 amRNSUpdate on Competitive Offtake Partnering Process
24th Jan 20247:00 amRNSCompletion of US$5m MIIF Subscription
23rd Jan 20247:00 amRNSTR-1 Notification of Major Holdings
2nd Jan 20247:00 amRNSCorporate Update - Director / PDMR Shareholding
29th Dec 20237:00 amRNSCorporate Update - Director / PDMR Shareholding
28th Dec 20237:00 amRNSGrant of PDMR Performance Rights
22nd Dec 20237:00 amRNSDirector / PDMR Dealings & Shareholding Update
21st Dec 20237:00 amRNSCorporate Update - Director / PDMR Dealings
20th Dec 20237:00 amRNSBoard Changes
15th Dec 20237:00 amRNSSuccessful Completion of A$8million Equity Placing
14th Dec 20234:45 pmRNSA$7 million Equity Placing
12th Dec 20237:00 amRNSMaiden Feldspar Mineral Resource Estimate
30th Nov 202311:57 amRNSAmended Constitution
30th Nov 202311:50 amRNSResult of Annual General Meeting
30th Nov 20237:02 amRNSAGM Statement
28th Nov 20237:00 amRNS106m Continuous Pegmatite Interval Reported
23rd Nov 20239:39 amRNSUpdated Quarterly Activities and Cash Flow Report
22nd Nov 20237:00 amRNSProject Development Update
16th Nov 20237:00 amRNSInvestor Presentation - Noosa Mining Conference
15th Nov 20237:00 amRNSRejection of Non-Binding Indicative Offers
14th Nov 20237:00 amRNSGrant of Highly Prospective Licences for Lithium
10th Nov 20237:00 amRNSConference Attendance
7th Nov 20237:00 amRNSAdditional Resource Extension Drilling Planned
1st Nov 20237:00 amRNSChange of Registered Office
31st Oct 20237:05 amRNSNotice of AGM
31st Oct 20237:00 amRNSQuarterly Activities and Cash Flow Report
20th Oct 20237:00 amRNSMining Lease Granted for Ewoyaa Lithium Project
19th Oct 202311:35 amRNSStatement re Media Speculation
13th Oct 20237:00 amRNSConference Attendance
10th Oct 20237:00 amRNSApproval to Divert Transmission Lines at Ewoyaa
29th Sep 20239:55 amRNSInvestor Presentation
28th Sep 20237:00 amRNS2023 Annual Financial Report
21st Sep 20237:00 amRNSNotice of Results and Investor Presentation
15th Sep 20237:00 amRNSConference Attendance
8th Sep 20237:05 amRNSInvestor Presentation
8th Sep 20237:00 amRNSUS$32.9m Strategic Investment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.